Marketing Oversight By States Creates Multiple Compliance Standards For Firms
Executive Summary
As more and more states pass laws that require pharmaceutical companies to disclose payments to health care practitioners, there needs to be a single definition of which data must be reported, according to John Patrick Oroho, executive vice president of Porzio Pharmaceutical Services (see chart: "1Marketing Disclosure/Gift Limitation Laws")You may also be interested in...
Physician Payment Disclosure Bill Should Include Other Entities – MedPAC
The Medicare Payment Advisory Commission is recommending a more comprehensive system for reporting pharmaceutical industry payments than the one proposed in legislation pending before Congress
Physician Payment Disclosure Bill Should Include Other Entities – MedPAC
The Medicare Payment Advisory Commission is recommending a more comprehensive system for reporting pharmaceutical industry payments than the one proposed in legislation pending before Congress
Mass. Ethics Code Compromises Drug Development, Industry Says
Reporting provisions in state law signed Aug. 10 expose clinical researchers, drug company programs, state and national organizations say.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: